trending Market Intelligence /marketintelligence/en/news-insights/trending/ejnPrVliR7ZPqKYzuiOJ9w2 content esgSubNav
In This List

US FDA clears Roche's Elecsys blood test for potential heart attack

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond


US FDA clears Roche's Elecsys blood test for potential heart attack

The U.S. FDA approved Roche Holding Ltd.'s Elecsys troponin T blood test to diagnose patients with a suspected heart attack.

This makes Roche the first in-vitro diagnostics company in the U.S. to provide the next generation blood test.